Zhongchao (ZCMD) Total Non-Current Liabilities (2021 - 2022)
Zhongchao (ZCMD) posted quarterly Total Non-Current Liabilities of -$31.6 million for Q4 2022, up 3.0% year-on-year from -$30.7 million in Q4 2021, and up 3.0% on a QoQ basis from -$32.6 million in Q4 2021.
Zhongchao (ZCMD) Total Non-Current Liabilities (2021 - 2022) Analysis & Trends
Zhongchao (ZCMD) has reported Total Non-Current Liabilities for 2 consecutive years, with -$31.6 million the latest figure, recorded in Q4 2022.
- Quarterly Total Non-Current Liabilities rose 3.0% year-over-year to -$31.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$31.6 million (up 3.0% YoY) and the FY2022 annual result came in at -$31.6 million, up 3.0% from the prior year.
- Total Non-Current Liabilities improved to -$31.6 million in Q4 2022 per ZCMD's latest filing, from -$32.6 million in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for ZCMD reached as high as -$31.6 million in Q4 2022 and fell as low as -$32.6 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | 1.79 Bn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 4.14 Bn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | 1.12 Bn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | - |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 195.02 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 702.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | 1.90 Bn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | 163.45 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | 10.69 Mn |
| 10 | Zhongchao | 44,474.76 | -19.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -31.59 Mn |
| Dec 31, 2021 | -32.57 Mn |